Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 8/20 | 0.34 |
| ▸ | FAAH | O00519 | 8/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GRK2 | P25098 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL1533994 | 0.92 | EPHX1 (0.47) | EPHX1CES1FAAHCES2DNM1 | |
| Trifluoromethanesulfonic Acid SCHEMBL10660726 | 0.88 | DNM1 (0.44) | EPHX1MEN1KMT2ADNM1LMNA | |
| Tetrabuthylammonium SCHEMBL160606 | 0.85 | SLC22A1 (0.52) | EPHX1CES1FAAHCES2DNM1 | |
| Tributylmethylammonium SCHEMBL21463721 | 0.85 | EPHX1 (0.38) | EPHX1CES1FAAHCES2MEN1 | |
| Tributylmethylammonium SCHEMBL1627727 | 0.84 | TP53 (0.41) | DNM1SLC22A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL16700885 | 0.84 | DNM1 (0.48) | EPHX1MEN1KMT2ADNM1LMNA | |
| Tetrabuthylammonium SCHEMBL9308725 | 0.83 | SLC22A1 (0.50) | EPHX1CES1FAAHCES2DNM1 | |
| Tributylmethylammonium SCHEMBL28981157 | 0.83 | CA2 (0.46) | EPHX1DNM1SLC22A1 | |
| Tributylmethylammonium SCHEMBL30208818 | 0.83 | EPHX1 (0.37) | EPHX1CES1FAAHCES2MEN1 | |
| Tributylmethylammonium SCHEMBL3185188 | 0.83 | KCNH2 (0.41) | EPHX1FAAHMEN1KMT2ADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2287957-B1 | MAGNESIUM ION-CONTAINING NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE USING THE SAME | SONY CORP (JP) | 2014-07-23 | — | — | EP | claimed |
| US-8637192-B2 | Nonaqueous electrolytic solution containing magnesium ions, and electrochemical device using the same | SONY CORPORATION (JP) | 2014-01-28 | — | — | US | claimed |
| US-20110111286-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS, AND ELECTROCHEMICAL DEVICE USING THE SAME | SONY CORPORATION (JP) | 2011-05-12 | — | — | US | claimed |
| US-9793545-B2 | Magnesium battery comprising positive-electrode mixture with graphite fluoride and copper | SONY CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| EP-2287957-B1 | MAGNESIUM ION-CONTAINING NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE USING THE SAME | SONY CORP (JP) | 2014-07-23 | — | — | EP | disclosed |
| US-8637192-B2 | Nonaqueous electrolytic solution containing magnesium ions, and electrochemical device using the same | SONY CORPORATION (JP) | 2014-01-28 | — | — | US | disclosed |
| US-20130337328-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS, AND ELECTROCHEMICAL DEVICE USING THE SAME | SONY CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20110111286-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS, AND ELECTROCHEMICAL DEVICE USING THE SAME | SONY CORPORATION (JP) | 2011-05-12 | — | — | US | disclosed |
| US-7659430-B2 | Method for separating hydrogen chloride and phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-09 | — | — | US | disclosed |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | PSPH, SLC9B2, HVCN1 | EPHX1 3892/4885CES1 4335/4885FAAH 3873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.